Oral solid dosage forms containing dihydroartemisinin, a semi-synthetic antimalarial agent. Procured by pharmaceutical wholesalers, hospitals, and clinics in malaria-endemic regions for treatment protocols. Manufactured by API suppliers and tablet press operators adhering to GMP standards in global supply chains.